BIM-018
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| ChemSpider | 29763750 |
| Chemical and physical data | |
| Formula | C23H22N2O |
| Molar mass | 342.4 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
BIM-018 is a synthetic cannabinoid that is the benzimidazole analog of JWH-018. It is presumed to be a potent agonist of the CB2 receptor and has been sold online as a designer drug.[1]
Related benzimidazole derivatives have been reported to be highly selective agonists for the CB2 receptor.[2]
See also
References
- ↑ "BIM-018". Cayman Chemical. Retrieved 24 July 2015.
- ↑ Daniel Pagé; Elise Balaux; Luc Boisvert; Ziping Liu; Claire Milburn; Maxime Tremblay; Zhongyong Wei; Simon Woo; Xuehong Luo; Yun-Xing Cheng; Hua Yang; Sanjay Srivastava; Fei Zhou; William Brown; Miroslaw Tomaszewski; Christopher Walpole; Leila Hodzic; Stéphane St-Onge; Claude Godbout; Dominic Salois; Keymal Payza (July 2008). "Novel benzimidazole derivatives as selective CB2 agonists". Bioorganic & Medicinal Chemistry Letters. 18 (13): 3695–3700. doi:10.1016/j.bmcl.2008.05.073. PMID 18522867.
This article is issued from Wikipedia - version of the 8/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.